Nevertheless, studies in transgenic mice models of AD have suggested that specific changes in p‐tau metabolism followed those of Aβ (Maia et al, 2013; Mattsson‐Carlgren et al, 2020). The gene discussed is MAPT; the disease is Alzheimer disease.